Walleye Trading
GBT

Walleye Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Walleye Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-245,000
Closed -$16.7M – 5823
2022
Q3 		$16.7M Buy
+245,000
New +$13.5M 0.05% 399
2022
Q2 		– Sell
-3,300
Closed -$114K – 5910
2022
Q1 		$114K Sell
3,300
-4,600
-58% -$138K ﹤0.01% 4172
2021
Q4 		$231K Buy
7,900
+3,600
+84% +$112K ﹤0.01% 3747
2021
Q3 		$110K Sell
4,300
-44,600
-91% -$1.31M ﹤0.01% 4311
2021
Q2 		$1.71M Buy
+48,900
New +$1.91M 0.01% 1625
2021
Q1 		– Sell
-20,700
Closed -$897K – 5525
2020
Q4 		$897K Buy
+20,700
New +$1.02M ﹤0.01% 2082
2020
Q3 		– Sell
-9,900
Closed -$625K – 4804
2020
Q2 		$625K Sell
9,900
-8,300
-46% -$569K ﹤0.01% 2076
2020
Q1 		$930K Sell
18,200
-16,400
-47% -$1.1M 0.01% 1358
2019
Q4 		$2.75M Sell
34,600
-13,400
-28% -$794K 0.02% 973
2019
Q3 		$2.33M Sell
48,000
-11,700
-20% -$610K 0.02% 922
2019
Q2 		$3.14M Buy
59,700
+23,300
+64% +$1.34M 0.03% 732
2019
Q1 		$1.93M Buy
36,400
+27,600
+314% +$1.36M 0.02% 1101
2018
Q4 		$361K Buy
+8,800
New +$330K ﹤0.01% 2816
2018
Q1 		– Sell
-300
Closed -$12 – 4903
2017
Q4 		$12 Buy
+300
New +$11.2K ﹤0.01% 4231

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's GBT Position: Q2 2022 in Review

Walleye Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 4,663 shares — an estimated $162K sold.

Walleye Trading first reported a position in GBT in Q4 2017 and held it in 7 quarters. The position peaked at $3.38M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Walleye Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 4,663 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $162K.
  • Walleye Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 7 quarters.
  • Walleye Trading's Global Blood Therapeutics, Inc. position peaked at $3.38M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.